Status:

UNKNOWN

Clinical Study of the Effect of Methylprednisolone Combined

Lead Sponsor:

Qianfoshan Hospital

Conditions:

Methylprednisolone;Dihydroxypropyltheophylline;One Lung Ventilation;Respiratory Dynamics

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Through the design of RCT study, the preoperative use of drugs (methylprednisolone + dihydroxypropyltheophylline) as intervention measures, the patients undergoing thoracoscopic lobectomy as the main ...

Eligibility Criteria

Inclusion

  • 1\. After fully understanding the purpose and significance of the trial, the patients voluntarily participated in the trial and signed the informed consent;
  • 2\. The type of operation was general anesthesia and thoracoscopic lobectomy;
  • 3\. Age 18-75 years old, including boundary value, gender is not limited;
  • 4\. BMI 18-26kg / m2;
  • 5\. ASA grade I-II; no mental disorder, normal consciousness, normal communication;
  • 6\. No contraindications of methylprednisolone and dihydroxypropyltheophylline.

Exclusion

  • 1\. There were diseases of immune, endocrine, nervous and mental system before operation, and serious dysfunction of heart, liver and kidney;
  • 2\. Take immunosuppressive drugs and non steroidal anti-inflammatory drugs before operation;
  • 3\. Respiratory tract infection (cough, expectoration, suffocation, etc.) in recent 1 month; pneumonia, bronchitis, etc. on CT;
  • 4\. History of chronic pulmonary disease, including but not limited to asthma, pulmonary abscess, tuberculosis, chronic bronchitis, etc;
  • 5\. FEV1 \< 50%;
  • 6\. Oxygen saturation was lower than 90% and airway pressure was higher than 40 cm H20;
  • 7\. Continuous hypotension or hypertension during the operation; intraoperative blood loss \> 1000ml;
  • 8\. Allergic to methylprednisolone or dihydroxypropyltheophylline;
  • 9\. There are any other situations that the researchers think are not suitable for inclusion.

Key Trial Info

Start Date :

July 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2021

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT04810819

Start Date

July 1 2021

End Date

December 30 2021

Last Update

June 16 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.